Therapeutic targeting of NF-κB in myelodysplastic syndromes and acute myeloid leukaemia – the biological heterogeneity

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.14, Iss.11, 2010-11, pp. : 1139-1142

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

NF-κB as a potential therapeutic target in myelodysplastic syndromes and acute myeloid leukemia

By Breccia Massimo Alimena Giuliana

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 11, 2010-11 ,pp. : 1157-1176

Informa Healthcare

Access to resources Recommend Favorite

Azacitidine: A Review of its Use in the Management of Myelodysplastic Syndromes/Acute Myeloid Leukaemia

By Keating Gillian M.

Drugs, Vol. 72, Iss. 8, 2012-05 ,pp. : 1111-1136

Adis International

Access to resources Recommend Favorite

Azacitidine: A Review of its Use in Higher-Risk Myelodysplastic Syndromes/Acute Myeloid Leukaemia

By Keating Gillian M.

Drugs, Vol. 69, Iss. 17, 2009-12 ,pp. : 2501-2518

Adis International

Access to resources Recommend Favorite

Tositumomab/iodine-131 tositumomab: Acute myeloid leukaemia (first report) and myelodysplastic syndromes: 4 case reports

Reactions Weekly, Vol. 1, Iss. 1174, 2007-01 ,pp. : 25-26

Adis International

Access to resources Recommend Favorite

Targeting NF-κB for colorectal cancer

By Sakamoto Kei Maeda Shin

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 6, 2010-06 ,pp. : 593-601

Informa Healthcare

Access to resources Recommend Favorite